Patents by Inventor Daniel H. Wreschner

Daniel H. Wreschner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-MUC1 ?/? antibodies
    Patent number: 8648172
    Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: February 11, 2014
    Assignees: Biomodifying, LLC, Ramot at Tel Aviv University Ltd.
    Inventors: Daniel B. Rubinstein, Daniel H. Wreschner
  • ANTI-MUC1 ALPHA/BETA ANTIBODIES
    Publication number: 20120207772
    Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
    Type: Application
    Filed: November 16, 2011
    Publication date: August 16, 2012
    Applicants: BIOMODIFYING, LLC, RAMOT AT TEL AVIV UNIVERSITY, LTD.
    Inventors: DANIEL B. RUBINSTEIN, DANIEL H. WRESCHNER
  • Peptides and antibodies to MUC 1 proteins
    Patent number: 7897351
    Abstract: The invention relates to methods of inhibiting proliferation or growth of tumor cells and/or inducing cell death in cancer cells. This invention relates to the use of antibodies, hybridomas and pharmaceutical compositions containing same, for inhibiting growth or proliferation and inducing death in epithelial, colon, lung, breast and ovarian tumor cells or other cells which express MUC1 proteins.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: March 1, 2011
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Daniel H. Wreschner, Nechaama Ina Smorodinsky, Merav Yoeli-Lerner
  • SECRETED PATE-LIKE PROTEINS
    Publication number: 20100196351
    Abstract: Novel PATE-like polynucleotides and polypeptides, are provided. Also described are splice-variants resulting in smaller polypeptides including five cysteine residues and capable of forming PATE-like polypeptide multimerse. The described polynucleotides were found to have a surprising expression profile, predominantly in the reproduction system and nervous system. Further provided are pharmaceutical compositions and methods for treatment of various diseases, in particular nervous system disorders, more specifically Alzheimer's disease.
    Type: Application
    Filed: February 14, 2008
    Publication date: August 5, 2010
    Applicant: GENESWITCH INNOVATIONS LLC
    Inventor: Daniel H. Wreschner
  • Anti-Muc1 Alpha/Beta Antibodies
    Publication number: 20080226619
    Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
    Type: Application
    Filed: January 27, 2006
    Publication date: September 18, 2008
    Applicants: Ramot At Tel Aviv University, Ltd., Biomodifying, LLC
    Inventors: Daniel B. Rubinstein, Daniel H. Wreschner
  • Carrier sheets of paper and nitrocellulose bearing polyuridylic acid and polythymidylic acid residues and their use in the preparative recovery of MRNA
    Patent number: 4847165
    Abstract: A carried sheet being formed of a cellulose or a nitrocellulose derivative and coated with polyuridylic acid or polythymidylic acid or a mixture thereof. A method of using the carrier sheet for preparative recovery of mRNA.
    Type: Grant
    Filed: July 9, 1986
    Date of Patent: July 11, 1989
    Inventor: Daniel H. Wreschner